Elucidation of the role of kainate receptor subtypes in hippocampal synaptic function using novel pharmacological tools
Elucidation of the role of kainate receptor subtypes in hippocampal synaptic function using novel pharmacological tools
批准号:
BB/F012519/1
负责人:
David Jane
金额:
$88.43万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2008
资助国家:
英国
项目状态:
已结题
起止时间:
2008 至 --
中文摘要
这项拟议研究的主要目标是设计和合成新的化学物质,这些物质可以作为工具来研究大脑行使其多重功能的一些基本机制。具体地说,我们的目标是提供药理学工具来阐明一个神经细胞(神经元)与大脑中其他神经细胞(神经元)沟通的机制。这种交流是在神经元之间的连接(突触)处进行的。我们以前的工作帮助确定了神经链或网络中的一个细胞与下一个细胞通信的主要机制之一是通过从其多个突触末端释放一种氨基酸--谷氨酸。这种氨基酸通过突触间隙流向下一个神经元,并在那里与位于下一个神经元表面的蛋白质(谷氨酸受体)相互作用,产生控制第二个细胞电活动的电化学和/或生化变化。我们帮助建立了谷氨酸可以与一系列结构相关的蛋白质相互作用,这些蛋白质被称为谷氨酸受体亚型,每个亚型在中枢神经系统中发挥不同的功能。目前的工作旨在合成化学物质(药理工具),以阻断谷氨酸在特定谷氨酸受体亚型上的作用,这些亚型是由天然产物红藻氨酸(红藻氨酸受体)激活的。海人藻酸受体是由称为GluR5、GluR6、GluR7、KA1和Ka2的蛋白质亚单位组合而成的四聚体。虽然谷氨酸本身可以与所有这些亚基结合,导致受体激活,但目的是设计和化学合成被称为拮抗剂的药物,这些拮抗剂可以选择性地阻断GluR6、GluR7或KA1/Ka2亚基的激活。我们已经根据我们的GluR5配体结合核心与选择性GluR5亚单位拮抗剂络合物的X射线晶体结构生成了GluR6、GluR7和KA1配体结合核心的计算机模型。我们计划使用这些模型来设计分子,这些分子选择性地与配体结合核心中的亚基特定氨基酸残基相互作用,从而产生选择性的GluR6、GluR7或KA1/Ka2拮抗剂。通过观察红藻氨酸受体各亚基的特异性阻断对中枢神经系统功能的影响,可以推断该受体亚基在中枢神经活动综合模式中的特殊作用。海藻酸受体被认为在大脑中被称为海马体的部分存储记忆的基本机制中发挥作用,尽管由于缺乏特定的药理学工具,每个亚基在这些过程中的作用仍然存在争议。本项目开发的亚基特异性药理工具将使我们能够了解GluR6、GluR7和KA1/Ka2在这些机制中的作用。此外,我们计划生产放射性同位素标记的亚基选择性红藻氨酸受体拮抗剂。这将使我们能够可视化GluR6、GluR7或KA1/Ka2亚单位在特定大脑区域(如海马体)中的位置。
英文摘要
The main objective of the proposed research is to design and synthesize new chemical substances that can be used as tools to study some of the fundamental mechanisms by which the brain exercises its multiple functions. Specifically we aim to provide pharmacological tools to elucidate the mechanisms by which one nerve cell (neuron) communicates with others in the brain. This communication is effected at the junctions (synapses) between neurons. Our previous work has helped to establish that one of the main mechanisms by which one cell in a neuronal chain or network communicates with the next cell is by releasing an amino acid, glutamate from its multiple synaptic endings. This amino acid flows across the synaptic gap to the next neuron and there interacts with a protein (glutamate receptor) situated on the surface of the next neuron, to produce electrochemical and/or biochemical changes that control the electrical activity of the second cell. We have helped establish that glutamate can interact with a family of structurally related proteins known as glutamate receptor subtypes each performing different functions in the central nervous system. The present work aims to synthesize chemicals (pharmacological tools) that block the action of glutamate at particular glutamate receptor subtypes that are activated by the natural product kainic acid (kainate receptors). Kainate receptors are tetramers made up of a combination of protein subunits known as GluR5, GluR6, GluR7, KA1 and KA2. Whereas glutamate itself can bind to all of these subunits leading to receptor activation, the aim is to design and chemically synthesise agents known as antagonists that can selectively block the activation of GluR6, GluR7 or KA1/KA2 subunits. We have generated computer models of the ligand binding cores of GluR6, GluR7 and KA1 based on our X-ray crystal structures of the ligand binding core of GluR5 in complex with selective GluR5 subunit antagonists. We plan to use these models to design molecules that interact selectively with subunit specific amino acid residues in the ligand binding core, thereby producing selective GluR6, GluR7 or KA1/KA2 antagonists. By observing what the effect of specific blockade of each of the kainate receptor subunits has on the functioning of the central nervous system, one can deduce the particular roles of that receptor subunit in the integrated pattern of central nervous activity. Kainate receptors are thought to play a role in the fundamental mechanisms by which part of the brain known as the hippocampus stores memories, though the role of each individual subunit in these processes is still controversial due to the lack of specific pharmacological tools. Subunit specific pharmacological tools developed in this project will enable us to understand the role of GluR6, GluR7 and KA1/KA2 in these mechanisms. In addition, we plan to produce radioisotope labelled subunit selective kainate receptor antagonists. This will enable us to visualise the location of the GluR6, GluR7 or KA1/KA2 subunits within particular brain regions such as the hippocampus.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neuropharm.2012.06.051
发表时间:
2013-01
期刊:
Neuropharmacology
影响因子:
4.7
作者:
[Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE]
通讯作者:
Jane DE
DOI:
10.1016/j.neuint.2012.01.004
发表时间:
2012-09
期刊:
NEUROCHEMISTRY INTERNATIONAL
影响因子:
4.2
作者:
[Monaghan, Daniel T., Irvine, Mark W., Costa, Blaise Mathias, Fang, Guangyu, Jane, David E.]
通讯作者:
Jane, David E.
Textbook of Drug Design and Development
药物设计与开发教科书
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Jane DE]
通讯作者:
Jane DE
Identifying the role of NMDA receptors in STP through investigation of synaptic plasticity and discovery of novel subtype-specific antagonists
-
批准号:BB/L001977/1
-
项目类别:Research Grant
-
资助金额:$81.18万
-
财政年份:2014
-
负责人:David Jane
-
依托单位:
Discovering novel subtype-selective glutamate receptor antagonists for the study of hippocampal synaptic plasticity
-
批准号:G0601812/1
-
项目类别:Research Grant
-
资助金额:$236.01万
-
财政年份:2008
-
负责人:David Jane
-
依托单位:
国内基金
海外基金
水稻根长与抗旱基因RoLe1的克隆与分子机制解析
-
批准号:32401809
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:李颖秀
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: